Evidence map›Paper›PMID 38451256›Full record

ArticleeLife2024

Exploring factors shaping antibiotic resistance patterns in

Aleksandra Kovacevic, David R M Smith, Eve Rahbé, Sophie Novelli, Paul Henriot, Emmanuelle Varon, Robert Cohen, Corinne Levy, Laura Temime, Lulla Opatowski

Open access · goldAbstract read
In one paragraph

Article in eLife, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Clinical microbiology reviews · 2025
    Review
  5. Article
  6. Article
  7. Antimicrobial Activity ofInternational journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Aleksandra KovacevicInstitut Pasteur, Université Paris Cité, Epidemiology and Modelling of Antibiotic Evasion (EMAE) unit, Paris, France.ORCID https://orcid.org/0000-0001-9740-6207
David R M SmithInstitut Pasteur, Université Paris Cité, Epidemiology and Modelling of Antibiotic Evasion (EMAE) unit, Paris, France.
Eve RahbéInstitut Pasteur, Université Paris Cité, Epidemiology and Modelling of Antibiotic Evasion (EMAE) unit, Paris, France.ORCID https://orcid.org/0000-0002-3828-3910
Sophie NovelliUniversité Paris-Saclay, Université de Versailles Saint-Quentin-en-Yvelines, Inserm U1018, CESP, Anti-infective evasion and pharmacoepidemiology team, Montigny-Le-Bretonneux, France.
Paul HenriotModélisation, épidémiologie et surveillance des risques sanitaires (MESuRS), Conservatoire national des arts et métiers, Paris, France.
Emmanuelle VaronCentre National de Référence des Pneumocoques, Centre Hospitalier Intercommunal de Créteil, Créteil, France.
Robert CohenInstitut Mondor de Recherche Biomédicale-Groupe de Recherche Clinique Groupe d'Etude des Maladies Infectieuses Néonatales et Infantiles (IMRB-GRC GEMINI), Université Paris Est, 94000, Créteil, France.
Corinne LevyInstitut Mondor de Recherche Biomédicale-Groupe de Recherche Clinique Groupe d'Etude des Maladies Infectieuses Néonatales et Infantiles (IMRB-GRC GEMINI), Université Paris Est, 94000, Créteil, France.
Laura TemimeModélisation, épidémiologie et surveillance des risques sanitaires (MESuRS), Conservatoire national des arts et métiers, Paris, France.ORCID https://orcid.org/0000-0002-8850-5403
Lulla OpatowskiInstitut Pasteur, Université Paris Cité, Epidemiology and Modelling of Antibiotic Evasion (EMAE) unit, Paris, France.
Inserm · FRConservatoire National des Arts et Métiers · FRAssociation Française de Pédiatrie Ambulatoire · FRHôpital Intercommunal de Créteil · FR

Funding

Agence Nationale de la Recherche ANR-10-LABX-62 IBEIDAgence Nationale de la Recherche SPHINX-17-CE36-0008-01Fondation de France MODCOV Grant 106059Université Paris-Saclay AAP Covid-19 2020
6 · The paper itself

Abstract

Non-pharmaceutical interventions implemented to block SARS-CoV-2 transmission in early 2020 led to global reductions in the incidence of invasive pneumococcal disease (IPD). By contrast, most European countries reported an increase in antibiotic resistance among invasive

Indexed as

COVID-19Anti-Bacterial AgentsCommunicable Disease ControlHumansPandemicsSARS-CoV-2Streptococcus pneumoniaeAnti-Bacterial Agentsantibiotic resistanceCOVID-19 pandemicecologyepidemiologyglobal healthinvasive pneumococcal diseaseSARS-CoV-2Streptococcus pneumoniaevirus-bacteria interactions

Identifiers

PMID38451256
PMCPMC10923560
OpenAlexW4392575782

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.